Brief: Emyria Completes A$3M Placement To Advance Cannabinoid Registration And MDMA-Analogue Development
31/10/2022 01:48
Oct 31 (Reuters) - Emyria Ltd EMD.AX :
* COMPLETES A$3M PLACEMENT TO ADVANCE CANNABINOID
REGISTRATION AND
MDMA-ANALOGUE DEVELOPMENT
* PLACEMENT IS BEING CONDUCTED AT OFFER PRICE OF A$0.18 PER
SHARE
Further company coverage: EMD.AX
((Reuters.Briefs@thomsonreuters.com;))